UTMD

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Utah Medical Products, Inc.

Utah Medical Products, Inc. with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long term outcomes for their patients.
CEO
Kevin Cornwell
Employees
181
Headquarters

7043 S Cottonwood St
Midvale, Utah 84047-1048
Phone: 18015661200
www.utahmed.com

News

UTMD Stock Earnings: Utah Medical Products Reported Results for Q2 2024
Jul 26, 2024 02:54am

Utah Medical Products (NASDAQ: UTMD ) just reported results for the second quarter of 2024. Utah Medical Products reported earnings per share of 97.8 cents. The company reported revenue of $10.40 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace Legendary Investor Predicts: “Forget AI… THIS Technology Is the Future” The post UTMD Stock Earnings: Utah Medical Products Reported Results for Q2 2024 appeared first on InvestorPlace .


Source:InvestorPlace
Utah Medical Products, Inc.: UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2024
Jul 25, 2024 13:02pm

SALT LAKE CITY, UT / ACCESSWIRE / July 25, 2024 / As previously projected, Utah Medical Products, Inc. (Nasdaq:UTMD) realized second calendar quarter (2Q) and first half (1H) 2024 financial results…


Source:Finanz Nachrichten
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2024
Jul 25, 2024 13:00pm

SALT LAKE CITY, UT / ACCESSWIRE / July 25, 2024 / As previously projected, Utah Medical Products, Inc. (Nasdaq:UTMD) realized second calendar quarter (2Q) and first half (1H) 2024 financial results which reflect a substantial decline in … Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online